Scarica l'app Stockscreener
0.50
3.63%
0.0175
Dopo l'orario di chiusura:
.50
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
Harvard Bioscience enters retention agreement with interim CFO Mark Frost By Investing.com - Investing.com Nigeria
Harvard Bioscience Offers CFO $100K Retention Bonus - TipRanks
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience 2025 Q2 Earnings Narrows Losses with 22% Drop in Net Loss - AInvest
Harvard Bioscience Amends Credit Agreement with Lenders Amid Concerns Over Future Operations - AInvest
Is Now a Good Time to Reenter Harvard Bioscience Inc.Target Return Focused Trade Insights Shared - 선데이타임즈
Harvard Bioscience: Q2 Earnings Snapshot - Norwalk Hour
Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada
Harvard Bioscience Reports Q2 2025 Financial Results - TipRanks
Harvard Bioscience Q2 2025: Unpacking Contradictions in NIH Funding, Refinance Terms, and China Market Outlook - AInvest
Harvard Bioscience Amends Credit Agreement with Lenders - TipRanks
Harvard Bioscience Delivers Steady Results And Eyes Growth Ahead - Finimize
Harvard Bioscience Delivers Steady Results And Improved Cash Flow - Finimize
Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates - MSN
Harvard Bioscience Q2 2025 Earnings Call Transcript - MarketBeat
Harvard Bioscience: Navigating Debt and Innovation in the Biotech Tools Sector - AInvest
Harvard Bioscience sets Q3 revenue target at $19M-$21M, CEO outlines priorities for 2025. - AInvest
Harvard Bioscience earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
Earnings call transcript: Harvard Bioscience Q2 2025 results show mixed signals - Investing.com Nigeria
Transcript : Harvard Bioscience, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Harvard Bioscience Q2 2025 slides: improved profitability despite revenue challenges - Investing.com Canada
Harvard Bioscience's Q2 2025 Performance: A Strategic Turnaround Amid Debt Refinancing Challenges - AInvest
Harvard Bioscience Reports Q2 Earnings Beat, Initiates Q3 Outlook - AInvest
Harvard Bioscience Tops Q2 Revenue Views - The Motley Fool
Harvard Bioscience Tops Q2 Revenue Views - The Globe and Mail
Harvard Bioscience Q2 revenue meet estimates - MarketScreener
Harvard Bioscience Q2 2025 Financial Results - TradingView
Harvard Bioscience Announces Second Quarter 2025 Financial Results - GlobeNewswire
Harvard Bioscience Q2 Earnings: Revenue Beats Guidance as New CEO Charts Turnaround Path - Stock Titan
Will Harvard Bioscience Inc. benefit from macro trendsFree High Conviction Intraday Stock Signals - Newser
Harvard Bioscience Inc. stock daily chart insights2-Day Signal Watch with Forecast Outcome - Newser
Harvard Bioscience Inc. stock outlook for YEARStock Entry Points Based on Technicals - Newser
Why Harvard Bioscience Inc. stock attracts strong analyst attentionFree Real Time Alerts Based on AI Prediction - Newser
Relative strength of Harvard Bioscience Inc. in sector analysisFree Alert Feed for Momentum Based Picks - Newser
What earnings revisions data tells us about Harvard Bioscience Inc.Free Weekly Potential Breakout Stock List - Newser
Is Harvard Bioscience Inc. stock poised for growthReal Chart Based Opportunity Identification - Newser
Real time scanner hits for Harvard Bioscience Inc. explainedFree Proven Entry Plan With Low Risk Trade - Newser
Harvard Bioscience HBIO 2025Q2 Earnings Preview Upside Anticipated on Innovative Gene Therapy Developments - AInvest
Harvard Bioscience Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Earnings To Watch: Harvard Bioscience Inc (HBIO) Reports Q2 2025 Result - Yahoo Finance
Chart overlay techniques for tracking Harvard Bioscience Inc.AI Intraday Market Movement Prediction Tool - Newser
Harvard Bioscience Enters Sixth Amendment To Credit Agreement; Lenders Agree Not To Test Financial Covenants For Q3 2025; Agrees To Pay $400K Fees To Lenders; Explores Alternative Capital Sources For Refinancing; Says There Is Substantial Doubt - 富途牛牛
Harvard Bioscience announces CEO succession plan - MSN
Harvard Bioscience Sets Q2 2025 Earnings Release and Conference Call - AInvest
Harvard Bioscience, Inc. to Release Q2 2025 Financial Results and Host Conference Call on August 11, 2025 - Quiver Quantitative
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET - GlobeNewswire
Harvard Bioscience Upcoming Q2 2025 Earnings: Pre-Market Release and Conference Call Details Revealed - Stock Titan
Published on: 2025-08-04 19:22:29 - beatles.ru
Using R and stats models for Harvard Bioscience Inc. forecastingFree Capital Growth With Controlled Risk Picks - Newser
Harvard Bioscience Inc. Stock Analysis and ForecastInvest confidently with professional market insights - Jammu Links News
What are analysts’ price targets for Harvard Bioscience Inc. in the next 12 monthsFree Trading Psychology Coaching - Jammu Links News
What makes Harvard Bioscience Inc. stock price move sharplyPhenomenal trading returns - Jammu Links News
Is Harvard Bioscience Inc. stock overvalued or undervaluedUnlock exclusive trading tools and resources - Jammu Links News
What drives Harvard Bioscience Inc. stock priceBuild a portfolio for long-term financial success - Jammu Links News
How volatile is Harvard Bioscience Inc. stock compared to the marketUnlock your portfolio’s hidden potential - Jammu Links News
What is Harvard Bioscience Inc. company’s growth strategyPowerful market insights - Jammu Links News
Is Harvard Bioscience Inc. a growth stock or a value stockFree Capital Allocation Plans - Jammu Links News
How does Harvard Bioscience Inc. compare to its industry peersBuild a diversified portfolio for risk mitigation - Jammu Links News
When is Harvard Bioscience Inc. stock expected to show significant growthMassive profits - Jammu Links News
How Harvard Bioscience Inc. stock performs during market volatilityShort Squeeze Opportunities with Indicators - Newser
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):